ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 1.7.2 (20 November 2019) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification202007173063273CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120201230W172deBibliographieenBibliographyfrBibliographieEP14809770.2201410282016050920171026enenen1319051120131028EP2020123020205320160907201636201910162019422019050920191016AL20200116BG20191016CZ20191016DK20191016EE20191016FI20200117GR20191016HR20200216IS20191016LT20191028LU20191016LV20191016MC20191016PL20200217PT20191016RO20191016RS20191016SK20191016SM20201230202053C12N 7/01 20060101AFI20190405BHEP C12N 7/04 20060101ALI20190405BHEP C12N 15/86 20060101ALI20190405BHEP A61K 35/768 20150101ALI20190405BHEP deINFLUENZA-VIRUS-VEKTOR FÜR VIRENTHERAPIEenINFLUENZA VIRUS VECTOR FOR VIROTHERAPYfrVECTEUR À VIRUS INFLUENZA POUR VIROTHÉRAPIEEP-A1- 2 708 552WO-A1-2011/014504WO-A2-01/64860C. L. EFFERSON ET AL: "Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene", JOURNAL OF VIROLOGY, vol. 77, no. 13, July 2003 (2003-07), pages 7411-7424, XP055172262, ISSN: 0022-538X, DOI: 10.1128/JVI.77.13.7411-7424.2003KITTEL CHRISTIAN ET AL: "Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 79, no. 16, August 2005 (2005-08), pages 10672-10677, XP002414818, ISSN: 0022-538X, DOI: 10.1128/JVI.79.16.10672-10677.2005MUSTER T ET AL: "Interferon resistance promotes oncolysis by influenza virus NSI1-deletion mutants", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, vol. 110, no. 1, 20 May 2004 (2004-05-20), pages 15-21, XP008088723, ISSN: 0020-7136, DOI: 10.1002/IJC.20078M. WOLSCHEK ET AL: "Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency", JOURNAL OF VIROLOGY, vol. 85, no. 5, 22 December 2010 (2010-12-22), pages 2469-2473, XP055046389, ISSN: 0022-538X, DOI: 10.1128/JVI.01650-10BERGMANN MICHAEL ET AL: "A genetically engineered influenza A virus with ras-dependent oncolytic properties", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 61, no. 22, 15 November 2001 (2001-11-15), pages 8188-8193, XP002470603, ISSN: 0008-5472 cited in the applicationB. FERKO ET AL: "Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes", JOURNAL OF VIROLOGY, vol. 78, no. 23, 12 November 2004 (2004-11-12), pages 13037-13045, XP055090958, ISSN: 0022-538X, DOI: 10.1128/JVI.78.23.13037-13045.2004MUSTER, ThomasEckperggasse 40/6,1180 WienATBlue Sky Vaccines GmbH101641142MT001PEPMariahilfer Strasse 101/1/211060 ViennaATLoidl, Manuela Bettinaet al101171795REDL Life Science Patent Attorneys Donau-City-Straße 111220 WienATALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTREP201407312020141028enWO201506308520150507201518